This was the stock's fourth consecutive day of gains.

Boston Scientific (BSX) closed the most recent trading day at $99.22, moving +0.32% from the previous trading session. This move outpaced the S&P 500's daily loss of 1.07%. Meanwhile, the Dow lost ...

Boston Scientific has shown high revenue and EPS growth rates in recent years. See why I recommend a hold rating for BSX stock.

In the latest trading session, Boston Scientific (BSX) closed at $98.90, marking a +1.79% move from the previous day. This move outpaced the S&P 500's daily gain of 0.64%. Meanwhile, the Dow gained 0.

A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO ...

Boston Scientific Corp. closed 9.34% short of its 52-week high of $107.17, which the company reached on February 5th.

(RTTNews) - Boston Scientific Corp. (BSX), Monday announced its decision to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS Intravascular Ultrasound System.

Today's Research Daily features new research reports on 16 major stocks, including The Goldman Sachs Group, Inc. (GS), The Progressive Corp. (PGR) and Boston Scientific Corp. (BSX), as well as ...

MARLBOROUGH, Mass., Feb. 26, 2025 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE: BSX) today announced that American Medical Systems Europe B.V ...

The United States has historically made substantial scientific and monetary contributions to the IPCC. US scientists publish research that informs the assessment and run computer simulations of ...

TUESDAY, Feb. 25, 2025 (HealthDay News) -- Boston Scientific has issued a recall of Accolade pacemaker devices, according to a safety communication from the U.S. Food and Drug Administration. The ...